Targeting the IL-6/STAT3 Signalling Cascade to Reverse Tamoxifen Resistance in Estrogen Receptor Positive Breast Cancer

por Tsoi, Ho, Man, Ellen P. S., Chau, Ka Man, Khoo, Ui-Soon
Publicado 2021

Targeting Ribosome Biogenesis to Combat Tamoxifen Resistance in ER+ve Breast Cancer

por Tsoi, Ho, You, Chan-Ping, Leung, Man-Hong, Man, Ellen P. S., Khoo, Ui-Soon
Publicado 2022

Modulating the Activity of Androgen Receptor for Treating Breast Cancer

por You, Chan-Ping, Tsoi, Ho, Man, Ellen P. S., Leung, Man-Hong, Khoo, Ui-Soon
Publicado 2022

Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer

por Tsoi, Ho, Shi, Ling, Leung, Man-Hong, Man, Ellen P. S., So, Zi-Qing, Chan, Wing-Lok, Khoo, Ui-Soon
Publicado 2022

Phosphorylation independent eIF4E translational reprogramming of selective mRNAs determines tamoxifen resistance in breast cancer

por Gong, Chun, Tsoi, Ho, Mok, Ka Chun, Cheung, Jenny, Man, Ellen P. S., Fujino, Kazunari, Wong, Ashely, Lam, Eric W. F., Khoo, Ui-Soon
Publicado 2020

Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer

por Tsoi, Ho, Tsang, Wai-Chung, Man, Ellen P. S., Leung, Man-Hong, You, Chan-Ping, Chan, Sum-Yin, Chan, Wing-Lok, Khoo, Ui-Soon
Publicado 2022

SRSF5 Regulates the Expression of BQ323636.1 to Modulate Tamoxifen Resistance in ER-Positive Breast Cancer

por Tsoi, Ho, Fung, Nicholas Nok-Ching, Man, Ellen P. S., Leung, Man-Hong, You, Chan-Ping, Chan, Wing-Lok, Chan, Sum-Yin, Khoo, Ui-Soon
Publicado 2023

FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance

por Khongkow, Pasarat, Karunarathna, Upekha, Khongkow, Mattaka, Gong, Chun, Gomes, Ana R., Yagüe, Ernesto, Monteiro, Lara J., Kongsema, Mesayamas, Zona, Stefania, Man, Ellen P. S., Tsang, Janice W.-H., Coombes, R. Charles, Wu, Kou-Juey, Khoo, Ui-Soon, Medema, René H., Freire, Raimundo, Lam, Eric W.-F.
Publicado 2013

Targeting microtubules sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors

por Chin, Tan-Min, Boopathy, Gandhi T. K., Man, Ellen P.S., Clohessy, John G., Csizmadia, Eva, Quinlan, Margaret P, Putti, Thomas, Wan, Seow-Ching, Xie, Chen, Ali, Azhar, Wai, Fhu Chee, Ong, Yan Shan, Goh, Boon-Cher, Settleman, Jeff, Hong, Wanjin, Levantini, Elena, Tenen, Daniel G.
Publicado 2020

Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1

por Cai, Qiuyin, Zhang, Ben, Sung, Hyuna, Low, Siew-Kee, Kweon, Sun-Seog, Lu, Wei, Shi, Jiajun, Long, Jirong, Wen, Wanqing, Choi, Ji-Yeob, Noh, Dong-Young, Shen, Chen-Yang, Matsuo, Keitaro, Teo, Soo-Hwang, Kim, Mi Kyung, Khoo, Ui Soon, Iwasaki, Motoki, Hartman, Mikael, Takahashi, Atsushi, Ashikawa, Kyota, Matsuda, Koichi, Shin, Min-Ho, Park, Min Ho, Zheng, Ying, Xiang, Yong-Bing, Ji, Bu-Tian, Park, Sue K., Wu, Pei-Ei, Hsiung, Chia-Ni, Ito, Hidemi, Kasuga, Yoshio, Kang, Peter, Mariapun, Shivaani, Ahn, Sei Hyun, Kang, Han Sung, Chan, Kelvin Y. K., Man, Ellen P. S., Iwata, Hiroji, Tsugane, Shoichiro, Miao, Hui, Liao, Jiemin, Nakamura, Yusuke, Kubo, Michiaki, Delahanty, Ryan J., Zhang, Yanfeng, Li, Bingshan, Li, Chun, Gao, Yu-Tang, Shu, Xiao-Ou, Kang, Daehee, Zheng, Wei
Publicado 2014